Patent · US Active

Aminopyrimidine derivatives for use as modulators of kinase activity

US10080750B2 · kind B2 · utility

1Cited by

2References

10Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Ruoxi Lan · Waltham, US
Bayard R. Huck · Sudbury, US
Xiaoling Chen · Sharon, US
Lizbeth Celeste Deselm · Melrose, US
Hui Qiu · Lexington, US
Yufang Xiao · Lexington, US
Constantin Neagu · Belmont, US
Igor Mochalkin · Westford, US
Theresa L. Johnson · Salem, US

Key dates

Filing date	Apr 18, 2017
Grant date	Sep 25, 2018
Priority date	—
Expiry date	Apr 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel heterocyclic amine compounds according to Formula (I) and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.